focus -WSS

focus

author：fashion 2025-10-02 11:10:18 - browse：1

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A solution to the after

hotspot

WSS

Adam's Take: Intra

R1 RCM gets $5.8 billion buyout offer from private equity firm

Mirador, a new biotech startup, launches with $400 million

Community Health Systems hospitals under DOJ investigation

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

hotspot

focus

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

He's a Nobel laureate. Critics say he was misleading on Covid

Medical leaders decry Supreme Court decision on affirmative action

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

State Dept. review finds Biden bears some blame for Afghanistan failures

New documents shed light on MD Anderson Cancer Institute feud

New air purifier tech could be key to improving indoor air quality

Obesity drugs seen as possible treatment for liver disease MASH

The cancer drug shortage isn’t new — and neither are the solutions

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Wikipedia

Cancer, immunology, HIV research ensnared in fetal tissue politics

He's a Nobel laureate. Critics say he was misleading on Covid

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

CRISPR technology availability, affordability needs to be expanded

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Medicare inequities exacerbate Puerto Rico’s health disparities

explore

focus

hotspot

focus